Support the Henrietta Lacks Enhancing Cancer Research Act of 2019

Recipients

  • Your Representative

Contact

*Required fields
 
 

Message

Support HR 1966, the Henrietta Lacks Enhancing Cancer Research Act of 2019

Dear [Decision Maker],

As a supporter of the International Myeloma Foundation, I ask you to support H.R. 1966, the Henrietta Lacks Enhancing Cancer Research Act of 2019, legislation that would study barriers to clinical trial participation. Currently, only a small percent of patients participate in cancer clinical trials.

H.R. 1966 would require a study to be conducted on what barriers exist when it comes to participation in clinical trials and would provide Congress with recommendations on how to improve access to trials for cancer patients.




By eliminating the barriers to participation and increasing the diversity of clinical trials, the trials themselves will better represent that population the drug will treat, and create better, more inclusive data. Ultimately, improving access to trials helps the entire cancer community and will improve future therapies.

I urge you to support this important legislation.

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]